• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Proteolysis-targeting chimeras targeting epigenetic modulators: a promising strategy for oral cancer therapy.

作者信息

Jayaseelan Vijayashree Priyadharsini, Loganathan Kavitha, Pandi Anitha, Ramasubramanian Abilasha, Kannan Balachander, Arumugam Paramasivam

机构信息

Clinical Genetics lab, Centre for Cellular & Molecular Research, Saveetha Dental College & Hospital, Saveetha Institute of Medical & Technical Sciences [SIMATS], Saveetha University, Poonamallee High Road, Chennai, Tamil Nadu - 600077, India.

Department of Oral and Maxillofacial Pathology, Ragas Dental College and Hospital, East Coast Road, Uthandi, Chennai - 600 119. Affiliated to The Tamil Nadu Dr. MGR Medical University, Anna Salai, Guindy, Chennai - 600032, India.

出版信息

Epigenomics. 2023 Dec;15(23):1233-1236. doi: 10.2217/epi-2023-0293. Epub 2023 Nov 22.

DOI:10.2217/epi-2023-0293
PMID:37990892
Abstract
摘要

相似文献

1
Proteolysis-targeting chimeras targeting epigenetic modulators: a promising strategy for oral cancer therapy.靶向表观遗传调节剂的蛋白酶靶向嵌合体：一种有前景的口腔癌治疗策略。
Epigenomics. 2023 Dec;15(23):1233-1236. doi: 10.2217/epi-2023-0293. Epub 2023 Nov 22.
2
[Advances in the preclinical and clinical research of proteolysis targeting chimera].[蛋白酶靶向嵌合体的临床前和临床研究进展]
Sheng Wu Gong Cheng Xue Bao. 2023 Sep 25;39(9):3615-3627. doi: 10.13345/j.cjb.221040.
3
[Advances in targeted delivery of proteolysis targeting chimeras in cancer therapy].[癌症治疗中蛋白酶靶向嵌合体的靶向递送研究进展]
Sheng Wu Gong Cheng Xue Bao. 2023 Sep 25;39(9):3628-3643. doi: 10.13345/j.cjb.230006.
4
Targeting of SOS1: from SOS1 Activators to Proteolysis Targeting Chimeras.靶向 SOS1：从 SOS1 激活剂到蛋白水解靶向嵌合体。
Curr Pharm Des. 2023;29(22):1741-1746. doi: 10.2174/1381612829666230418114520.
5
Comprehensive Transcriptomic Analysis of Novel Class I HDAC Proteolysis Targeting Chimeras (PROTACs).新型 I 类 HDAC 蛋白水解靶向嵌合体（PROTACs）的综合转录组分析。
Biochemistry. 2023 Feb 7;62(3):645-656. doi: 10.1021/acs.biochem.2c00288. Epub 2022 Aug 10.
6
Crizotinib-based proteolysis targeting chimera suppresses gastric cancer by promoting MET degradation.克唑替尼靶向蛋白水解嵌合体通过促进 MET 降解抑制胃癌。
Cancer Sci. 2023 May;114(5):1958-1971. doi: 10.1111/cas.15733. Epub 2023 Feb 7.
7
In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy.用于靶向癌症治疗的原位白蛋白结合和酯酶特异性裂解的BRD4降解PROTAC
Biomaterials. 2023 Apr;295:122038. doi: 10.1016/j.biomaterials.2023.122038. Epub 2023 Feb 7.
8
Advances in AR-targeting chimeras: a case study of proteolysis-targeting chimeras from bench to bedside.靶向 AR 的嵌合体的研究进展：以蛋白水解靶向嵌合体为例从基础到临床。
Future Med Chem. 2022 Oct;14(20):1471-1489. doi: 10.4155/fmc-2022-0147. Epub 2022 Oct 10.
9
Proteolysis-targeting chimeras (PROTACs) in cancer therapy.蛋白水解靶向嵌合体（PROTACs）在癌症治疗中的应用。
Mol Cancer. 2022 Apr 11;21(1):99. doi: 10.1186/s12943-021-01434-3.
10
Antibody-Proteolysis Targeting Chimera Conjugate Enables Selective Degradation of Receptor-Interacting Serine/Threonine-Protein Kinase 2 in HER2+ Cell Lines.抗体-蛋白酶靶向嵌合体偶联物可选择性降解 HER2+ 细胞系中的受体相互作用丝氨酸/苏氨酸蛋白激酶 2。
Bioconjug Chem. 2023 Nov 15;34(11):2049-2054. doi: 10.1021/acs.bioconjchem.3c00366. Epub 2023 Nov 2.

引用本文的文献

1
Identification of Novel Potential Herbal Drug Targets against Beta-Catenin in the Treatment of Oral Squamous Cell Carcinoma.鉴定治疗口腔鳞状细胞癌中针对β-连环蛋白的新型潜在草药药物靶点。
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4181-4188. doi: 10.31557/APJCP.2024.25.12.4181.